دورية أكاديمية
أعرض في EDS

Detection of serious adverse drug reactions using diagnostic codes in the International Statistical Classification of Diseases and Related Health Problems.

التفاصيل البيبلوغرافية
العنوان: Detection of serious adverse drug reactions using diagnostic codes in the International Statistical Classification of Diseases and Related Health Problems.
المؤلفون: Gosselin A; Pharmacy Department and Research Unit in Pharmaceutical Practice, Centre hospitalier universitaire Sainte-Justine, Montreal, Quebec, Canada; ariane.gosselin.hsj@ssss.gouv.qc.ca., Chabut C; Pharmacy Department and Research Unit in Pharmaceutical Practice, Centre hospitalier universitaire Sainte-Justine, Montreal, Quebec, Canada., Duhamel A; Pharmacy Department and Research Unit in Pharmaceutical Practice, Centre hospitalier universitaire Sainte-Justine, Montreal, Quebec, Canada., Desjardins I; Archives Department, Centre hospitalier universitaire Sainte-Justine, Montreal, Quebec, Canada., Lebel D; Pharmacy Department and Research Unit in Pharmaceutical Practice, Centre hospitalier universitaire Sainte-Justine, Montreal, Quebec, Canada., Bussières JF; Pharmacy Department and Research Unit in Pharmaceutical Practice, Centre hospitalier universitaire Sainte-Justine, Montreal, Quebec, Canada.; Pharmacy Faculty, Université de Montréal, Montreal, Quebec, Canada.
المصدر: Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique [J Popul Ther Clin Pharmacol] 2020 Jul 23; Vol. 27 (3), pp. e35-e48. Date of Electronic Publication: 2020 Jul 23.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Codon Publications Country of Publication: Australia NLM ID: 101530023 Publication Model: Electronic Cited Medium: Internet ISSN: 2561-8741 (Electronic) Linking ISSN: 25618741 NLM ISO Abbreviation: J Popul Ther Clin Pharmacol Subsets: MEDLINE
أسماء مطبوعة: Publication: 2019- : Brisbane, Australia : Codon Publications
Original Publication: Toronto, Ontario : Canadian Society of Pharmacology and Therapeutics
مواضيع طبية MeSH: Diagnosis-Related Groups*, Drug-Related Side Effects and Adverse Reactions/*epidemiology, Adverse Drug Reaction Reporting Systems ; Canada/epidemiology ; Female ; Hospitalization ; Humans ; Infant, Newborn ; International Classification of Diseases ; Maternal-Child Health Services ; Pregnancy
مستخلص: Canadian hospitals are legally required to report serious adverse drug reactions (ADRs). This study aimed to assess the ability to detect serious ADRs from diagnostic codes and the potential benefit of adding stand-alone diagnostic codes to the regular process for detecting serious ADRs. In this descriptive study, clinical pharmacists and a reference work on drug-induced diseases allowed to identify diagnostic codes in the International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Canada (ICD-10-CA), reflecting clinical manifestations related to an ADR. Records for admissions to a large urban mother-child hospital in the fiscal year 2018-2019, as coded by medical archivists, were analysed. Of 69 ICD-10-CA diagnostic codes reflecting an ADR identified, 38 were included in the detailed analysis of patient records and 18 (which appeared in 130 admissions) deemed to indicate a serious ADR. Among the 130 admissions analysed, 70 serious ADRs were identified, of which 52 were previously detected by the regular process and 18 were not, increasing the detection of serious ADRs by 34.6% (18/52). These 18 serious ADRs were newly identified from 11 of the 18 codes reflecting clinical manifestation of a serious ADR. Adding ICD-10-CA diagnostic codes not associated with external cause codes can increase the capacity to detect serious ADRs in hospitals. Over a 12-month period, the use of 11 such diagnostic codes increased the detection capacity for serious ADRs by 34.6%.
Competing Interests: The authors stated that they have no financial or non-financial conflicts of interest in connection with this article.
(© 2020 Journal of Population Therapeutics and Clinical Pharmacology. All rights reserved.)
References: 1. Health Canada. Mandatory reporting of serious adverse drug reactions and medical device incidents by hospitals – Guidance Document [Internet]. 2019 [cited 2020 Feb 15]. Available from: https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting/drugs-devices/guidance/Mandatory-reporting-hospitals-eng.pdf.
2. Soyer J, Necsoiu D, Lebel D, et al. . . Codage des séjours patients par les archivistes médicaux du centre hospitalier universitaire Sainte-Justine: une source inestimable de données pour le pharmacien. Pharmactuel. 2018;51(4):237–45.
3. Ministère de la Santé et des Services sociaux du Québec. Feuille sommaire d’hospitalisation [Internet]. 2005 [cited 2020 Feb 15]. Available from: http://msssa4.msss.gouv.qc.ca/intra/formres.nsf/c6dfb077f4130b4985256e38006a9ef0/48879ba6eb1e905e85256ec10066c870.
4. Soyer J, Necsoiu D, Lebel D, et al. Comprendre la Classification Internationale des Maladies et la Classification Canadienne des Interventions: exemples d’utilisation pour le pharmacien hospitalier. Abstract Presented at Congrès de l’Association des pharmaciens des établissements de santé du Québec (APES), 2018 April 25–27, Drummondville, QC.
5. Canadian Institute for Health Information. Codes and classifications [Internet]. [cited 2020 Feb 15]. Available from: https://www.cihi.ca/en/codes-and-classifications.
6. Collège de médecins du Québec. La tenue des dossiers par le médecin en centre hospitalier de soins généraux et spécialisés – Guide d’exercice [Internet]. 2005 Dec [cited 2020 Mar 30]. Available from: http://www.cmq.org/publications-pdf/p-1-2005-12-01-fr-tenue-des-dossiers-par-medecin-en-centre-hospitalier-de-soins-generaux-et-specialises.pdf.
7. Canadian Institute for Health Information. Canadian coding standards for version 2018 ICD-10-CA and CCI [Internet]. Ottawa, ON; 2018 [cited 2020 Apr 2]. Available from: https://secure.cihi.ca/free_products/CodingStandards_v2018_EN.pdf.
8. Ministère de la Santé et des Services sociaux du Québec. Cadre normatif du système MED-ÉCHO [Internet]. 1987 [revised 2019 Apr; cited 2020 Mar 23]. Available from: https://publications.msss.gouv.qc.ca/msss/fichiers/2000/00-601.pdf.
9. Tisdale JE, Douglas MA. Drug-induced diseases: Prevention, detection and management. 3rd ed. Bethesda, MD: American Society of Health-System pharmacists; 2018.
10. Régie de l’assurance maladie du Québec (RAMQ). Facturation: Répertoire des diagnostics [Internet]. [cited 2020 Feb 15]. Available from: https://www.ramq.gouv.qc.ca/fr/professionnels/medecins-specialistes/facturation/repertoire-diagnostics/Pages/repertoire-diagnostics.aspx.
11. Canadian Institute for Health Information. International statistical classification of diseases and related health problems, tenth revision (ICD-10-CA) – Volume 1, Tabular List [Internet]. Ottawa, ON; 2009 [cited 2020 Apr 7]. Available from: http://sda.chass.utoronto.ca/sdaweb/cihi/2009to2011/clin/more_doc/version_2009_icd-10-ca_tabular_list_volume_1.pdf.
12. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45. (PMID: https://doi.org/10.1038/clpt.1981.154)
13. Skalli S, Lebel D, Bussières J-F. Classification internationale des maladies et pharmacovigilance: passage de la révision 9 à la révision 10 en établissement de santé. Pharmactuel. 2011;44(1):42–7.
14. Soyer J, Necsoiu D, Desjardins I, et al. Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting and coding. Arch Pediatr. 2019;26(7):400–06. (PMID: https://doi.org/10.1016/j.arcped.2019.09.004)
15. Rault P, Necsoiu D, Desjardins I, et al. Preparing for Vanessa’s Law: Collaboration between the medical records and pharmacy departments at a Canadian hospital center. J Popul Ther Clin Pharmacol. 2019;26(2):e5–e13. (PMID: https://doi.org/10.15586/jptcp.v26i2.607)
16. Hohl CM, Karpov A, Reddekopp L, et al. ICD-10 codes used to identify adverse drug events in administrative data: A systematic review. J Am Med Inform Assoc. 2014 May–Jun;21(3):547–57. (PMID: https://doi.org/10.1136/amiajnl-2013-002116)
17. Du W, Pearson SA, Buckley NA, et al. Diagnosis-based and external cause-based criteria to identify adverse drug reactions in hospital ICD-coded data: Application to an Australia population-based study. Public Health Res Pract. 2017;27(2):2721716. (PMID: https://doi.org/10.17061/phrp2721716)
18. Kuklik N, Stausberg J, Jöckel KH. Adverse drug events in German hospital routine data: A validation of International Classification of Diseases, 10th revision (ICD-10) diagnostic codes. PLoS One. 2017 Nov;12(11):e0187510. (PMID: https://doi.org/10.1371/journal.pone.0187510)
19. Kuklik N, Stausberg J, Amiri M, et al. Improving drug safety in hospitals: A retrospective study on the potential of adverse drug events coded in routine data. BMC Health Serv Res. 2019 Aug;19(1):555. (PMID: https://doi.org/10.1186/s12913-019-4381-x)
20. Parameswaran Nair N, Chalmers L, Peterson GM, et al. Prospective identification versus administrative coding of adverse drug reaction-related hospitalizations in the elderly: A comparative analysis. Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1281–85. (PMID: https://doi.org/10.1002/pds.4667)
21. Bellis JR, Kirkham JJ, Nunn AJ, Pirmohamed M. Clinical coding of prospectively identified paediatric adverse drug reactions – A retrospective review of patient records. BMC Pharmacol Toxicol. 2014 Dec;15:72. (PMID: https://doi.org/10.1186/2050-6511-15-72)
22. McMaster C, Liew D, Keith C, et al. A machine-learning algorithm to optimise automated adverse drug reaction detection from clinical coding. Drug Saf. 2019 Jun;42(6):721–25. (PMID: https://doi.org/10.1007/s40264-018-00794-y)
فهرسة مساهمة: Keywords: International Statistical Classification of Diseases and Related Health Problems; diagnostic codes; hospital; pharmacovigilance; serious adverse drug reactions
تواريخ الأحداث: Date Created: 20200807 Date Completed: 20210917 Latest Revision: 20210917
رمز التحديث: 20221213
DOI: 10.15586/jptcp.v27i3.705
PMID: 32757540
قاعدة البيانات: MEDLINE
الوصف
تدمد:2561-8741
DOI:10.15586/jptcp.v27i3.705